BackgroundCheck.run
Search For

David T Smiley, 38Saratoga, CA

David Smiley Phones & Addresses

Saratoga, CA   

369 Bluefish Dr APT 3, Ft Walton Bch, FL 32548   

Fort Walton Beach, FL   

228 Seville Cir, Mary Esther, FL 32569    850-5812430   

Indianapolis, IN   

Mentions for David T Smiley

Career records & work history

Medicine Doctors

David C. Smiley

Specialties:
Internal Medicine
Work:
North Clinic
50 Central Ave, Osseo, MN 55369
763-4201900 (phone) 763-4201901 (fax)
Site
North Clinic
3366 Oakdale Ave N STE 215, Minneapolis, MN 55422
763-5877900 (phone) 763-5877989 (fax)
Site
Education:
Medical School
University of Wisconsin Medical School
Graduated: 1986
Procedures:
Electrocardiogram (EKG or ECG), Vaccine Administration
Conditions:
Abnormal Vaginal Bleeding, Acute Bronchitis, Acute Pancreatitis, Acute Pharyngitis, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Anxiety Phobic Disorders, Aortic Valvular Disease, Atrial Fibrillation and Atrial Flutter, Attention Deficit Disorder (ADD), Benign Paroxysmal Positional Vertigo, Benign Prostatic Hypertrophy, Bronchial Asthma, Chronic Renal Disease, Cirrhosis, Contact Dermatitis, Dementia, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Diverticulosis, Erectile Dysfunction (ED), Fractures, Dislocations, Derangement, and Sprains, Gastroesophageal Reflux Disease (GERD), Gout, Heart Failure, Hypertension (HTN), Hypothyroidism, Iron Deficiency Anemia, Ischemic Heart Disease, Migraine Headache, Multiple Sclerosis (MS), Osteoarthritis, Osteoporosis, Peripheral Nerve Disorders, Phlebitis and Thrombophlebitis, Pneumonia, Pulmonary Embolism, Rheumatoid Arthritis, Skin and Subcutaneous Infections, Thoracid Aortic Aneurysm, Urinary Incontinence, Venous Embolism and Thrombosis, Vitamin D Deficiency
Languages:
English, Spanish
Description:
Dr. Smiley graduated from the University of Wisconsin Medical School in 1986. He works in Robbinsdale, MN and 1 other location and specializes in Internal Medicine. Dr. Smiley is affiliated with Maple Grove Hospital and North Memorial Medical Center.

David A. Smiley

Specialties:
Internal Medicine
Work:
Elm Place Medical
800 N Westmoreland Rd STE 202, Lake Forest, IL 60045
847-2342488 (phone) 847-4331389 (fax)
Mark A Greenberger MD SC
480 Elm Pl STE 203, Highland Park, IL 60035
847-4330404 (phone) 847-4331389 (fax)
Education:
Medical School
Medical College of Wisconsin School of Medicine
Graduated: 2003
Procedures:
Cardiac Stress Test, Thyroid Biopsy, Arthrocentesis, Destruction of Benign/Premalignant Skin Lesions, Electrocardiogram (EKG or ECG), Pulmonary Function Tests, Skin Tags Removal, Vaccine Administration
Conditions:
Abdominal Hernia, Acute Myocardial Infarction (AMI), Acute Pancreatitis, Acute Renal Failure, Acute Upper Respiratory Tract Infections, Alopecia Areata, Anemia, Atherosclerosis, Atrial Fibrillation and Atrial Flutter, Attention Deficit Disorder (ADD), Benign Paroxysmal Positional Vertigo, Benign Prostatic Hypertrophy, Calculus of the Urinary System, Candidiasis, Cardiac Arrhythmia, Carpel Tunnel Syndrome, Cataract, Cholelethiasis or Cholecystitis, Chronic Bronchitis, Chronic Renal Disease, Conduction Disorders, Constipation, Contact Dermatitis, Dementia, Dermatitis, Diverticulitis, Erectile Dysfunction (ED), Gastritis and Duodenitis, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Hemorrhage, Gout, Hearing Loss, Heart Failure, Hemorrhagic stroke, Hemorrhoids, Herpes Simplex, Herpes Zoster, Hyperthyroidism, Hypothyroidism, Inflammatory Bowel Disease (IBD), Inguinal Hernia, Internal Derangement of Knee Cartilage, Intestinal Obstruction, Iron Deficiency Anemia, Irritable Bowel Syndrome (IBS), Ischemic Bowel Disease, Ischemic Heart Disease, Ischemic Stroke, Lateral Epicondylitis, Malignant Neoplasm of Female Breast, Migraine Headache, Mitral Valvular Disease, Non-Toxic Goiter, Obstructive Sleep Apnea, Osteoarthritis, Osteoporosis, Overweight and Obesity, Parkinson's Disease, Peripheral Nerve Disorders, Plantar Warts, Pneumonia, Prostatitis, Pulmonary Embolism, Restless Leg Syndrome, Rheumatoid Arthritis, Rotator Cuff Syndrome and Allied Disorders, Sciatica, Septicemia, Skin Cancer, Spinal Stenosis, Tempromandibular Joint Disorders (TMJ), Tinea Pedis, Tinea Unguium, Transient Cerebral Ischemia, Urinary Incontinence, Urinary Tract Infection (UT), Varicose Veins, Venous Embolism and Thrombosis, Vitamin D Deficiency, Abdominal Aortic Aneurysm, Acne, Acute Bronchitis, Acute Conjunctivitis, Acute Pharyngitis, Acute Sinusitis, Alcohol Dependence, Alzheimer's Disease, Anal Fissure, Anal or Rectal Abscess, Angina Pectoris, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Aortic Valvular Disease, Appendicitis, Arterial Thromboembolic Disease, Bell's Palsy, Benign Thyroid Diseases, Bipolar Disorder, Bronchial Asthma, Burns, Candidiasis of Vulva and Vagina, Cardiomyopathy, Chickenpox, Cirrhosis, Dehydration, Diabetes Mellitus (DM), Diabetic Peripheral Neuropathy, Disorders of Lipoid Metabolism, Diverticulosis, Emphysema, Epilepsy, Esophagitis, Fractures, Dislocations, Derangement, and Sprains, Gingival and Periodontal Diseases, Glaucoma, Hallux Valgus, Hemolytic Anemia, Hypertension (HTN), Infectious Liver Disease, Infectious Mononucleosis, Insomnia, Intervertebral Disc Degeneration, Intracranial Injury, Labyrinthitis, Lyme Disease, Macular Degeneration, Melanoma, Meningitis, Menopausal and Postmenopausal Disorders, Multiple Sclerosis (MS), Myasthenia Gravis (MG), Obsessive-Compulsive Disorder (OCD), Orbital Infection, Osteomyelitis, Otitis Media, Paroxysmal Supreventricular Tachycardia (PSVT), Peptic Ulcer Disease, Pericardidtis, Phlebitis and Thrombophlebitis, Plantar Fascitis, Poisoning by Drugs, Meds, or Biological Substances, Post Traumatic Stress Disorder (PTSD), Psoriasis, Raynaud's Disease, Retinal Detachments, Rosacea, Sarcoidosis, Schizophrenia, Sickle-Cell Disease, Skin and Subcutaneous Infections, Substance Abuse and/or Dependency, Systemic Lupus Erythematosus, Tension Headache, Thyroid Cancer, Thyroiditis, Ventral Hernia
Languages:
English, Spanish
Description:
Dr. Smiley graduated from the Medical College of Wisconsin School of Medicine in 2003. He works in Highland Park, IL and 1 other location and specializes in Internal Medicine. Dr. Smiley is affiliated with Highland Park Hospital and Northwestern Lake Forest Hospital.

License Records

David A Smiley

Licenses:
License #: 135001 - Expired
Issued Date: May 23, 2013
Expiration Date: Apr 19, 2016
Type: Salesperson

David G Smiley

Licenses:
License #: E085395 - Active
Category: Emergency medical services
Issued Date: Jan 6, 2011
Expiration Date: May 31, 2019
Type: San Francisco EMS Agency

David Smiley resumes & CV records

Resumes

David Smiley Photo 51

David Smiley

David Smiley Photo 52

Truck Driver

Work:

Truck Driver
David Smiley Photo 53

David Smiley

David Smiley Photo 54

David Smiley

David Smiley Photo 55

David Smiley

David Smiley Photo 56

David Smiley

Location:
United States

Publications & IP owners

Wikipedia

David Smiley Photo 60

Kim Philby

…e was implicated in a similar campaign in Albania. Colonel David Smiley, an aristocratic Guards officer who had helped Enver Hoxha and his Communist guerillas to liberate Albania, now prepared to liberate it from Hoxha. He trained Albanian commandos some of whom were former Nazi collaborato...
David Smiley Photo 61

David Smiley

Colonel David de Crespigny Smiley, LVO, OBE, MC & Bar (11 April 1916 9 January 2009) was a British special forces and intelligence officer. ...

Us Patents

Glucagon Analogs Exhibiting Physiological Solubility And Stability

US Patent:
8338368, Dec 25, 2012
Filed:
Nov 6, 2006
Appl. No.:
12/092802
Inventors:
Richard D. Dimarchi - Carmel IN, US
David L. Smiley - Bloomington IN, US
Assignee:
Indiana University Research and Technology Corporation - Indianapolis IN
International Classification:
A61K 38/26
C07K 14/605
US Classification:
514 72, 530308
Abstract:
Modified glucagon peptides are disclosed having improved solubility and stability, wherein the native glucagon peptide has been modified by pegylation, or the addition of a carboxy terminal peptide selected from the group consisting of SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, or both.

Glucagon Analogs Exhibiting Enhanced Solubility And Stability In Physiological Ph Buffers

US Patent:
8450270, May 28, 2013
Filed:
Jun 16, 2009
Appl. No.:
12/999284
Inventors:
Richard D. Dimarchi - Carmel IN, US
David L. Smiley - Bloomington IN, US
Maria Dimarchi - Carmel IN, US
Joseph Chabenne - Fishers IN, US
Jonathan Day - Bloomington IN, US
Assignee:
Indiana University Research and Technology Corporation - Indianapolis IN
International Classification:
A61K 35/00
US Classification:
514 68, 514 69, 514 117
Abstract:
Modified glucagon peptides are disclosed having improved solubility and/or half-life while retaining glucagon agonist activity. The glycogen peptides have been modified by substitution of native amino acids with, and/or addition of, charged amino acids to the carboxy terminus of the peptide. The modified glucagon agonists can be further modified by pegylation, or the addition of a carboxy terminal peptide selected from the group consisting of SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 23, or both to further enhance the solubility of the glucagon agonist analogs.

Glucagon/Glp-1 Receptor Co-Agonists

US Patent:
8546327, Oct 1, 2013
Filed:
Jun 16, 2009
Appl. No.:
12/999283
Inventors:
Richard D. Dimarchi - Carmel IN, US
David L. Smiley - Bloomington IN, US
Maria Dimarchi - Carmel IN, US
Joseph Chabenne - Fishers IN, US
Jonathan Day - Bloomington IN, US
James Patterson - Martinsville IN, US
Brian Ward - Lebanon IN, US
Assignee:
Indiana University Research and Technology Corporation - Indianapaolis IN
International Classification:
A61K 38/26
A61K 38/00
A61K 38/16
US Classification:
514 72, 514 69, 514 48, 514 213, 530324, 530308, 530345
Abstract:
Modified glucagon peptides are disclosed having enhanced potency at the glucagon receptor relative to native glucagon. Further modification of the glucagon peptides by forming intramolecular bridges or the substitution of the terminal carboxylic acid with an amide group produces peptides exhibiting glucagon/GLP-1 receptor co-agonist activity. The solubility and stability of these high potency glucagon analogs can be further improved by modification of the polypeptides by pegylation, acylation, alkylation, substitution of carboxy terminal amino acids, C-terminal truncation, or the addition of a carboxy terminal peptide selected from the group consisting of SEQ ID NO: 26 (GPSSGAPPPS), SEQ ID NO: 27 (KRNRNNIA) and SEQ ID NO: 28 (KRNR).

Melanocortin Receptor 4 (Mc4) Agonists And Their Uses

US Patent:
2007010, May 10, 2007
Filed:
Jun 17, 2004
Appl. No.:
10/556689
Inventors:
David Flora - Greenfield IN, US
Mark Heiman - Indianapolis IN, US
JeAnne Hertel - Indianapolis IN, US
Hansen Hsiung - Indianapolis IN, US
John Mayer - Indianapolis IN, US
David Smiley - Greenfield IN, US
Liang Yan - Carmel IN, US
Lianshan Zhang - Carmel IN, US
Assignee:
ELI LILLY AND COMPANY - INDIANAPOLIS IN
International Classification:
A61K 38/12
C07K 7/64
US Classification:
514009000, 530317000
Abstract:
The present invention relates to peptide agonists of the MC4 receptor, and as such are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and male and/or female sexual dysfunction.

Gip Receptor-Active Glucagon Compounds

US Patent:
2012017, Jul 5, 2012
Filed:
Jun 16, 2010
Appl. No.:
13/378001
Inventors:
Richard D. Dimarchi - Carmel IN, US
David L. Smiley - Bloomington IN, US
Maria Dimarchi - Carmel IN, US
Joseph Chabenne - Bloomington IN, US
Jonathan Day - San Diego IN, US
James Patterson - Bloomington IN, US
Brian P. Ward - Lebanon IN, US
Tao Ma - Bloomington IN, US
Assignee:
Indiana University Research And Technology Corp - Indianapolis IN
International Classification:
A61K 38/26
A61P 3/10
C07K 14/605
A61P 3/04
US Classification:
514 53, 514 68, 514 72, 514 117, 530324
Abstract:
Glucagon peptides with increased GIP activity are provided, optionally with GLP-I and/or glucagon activity. In some embodiments, C-terminally extended glucagon peptides comprising an amino acid sequence substantially similar to native glucagon are provided herein.

Glucagon Analogs Exhibiting Physiological Solubility And Stability

US Patent:
2012019, Aug 2, 2012
Filed:
Jan 24, 2012
Appl. No.:
13/357170
Inventors:
Richard D. DiMARCHI - Carmel IN, US
David L. SMILEY - Bloomington IN, US
Assignee:
Indiana University Research and Technology Corporation - Indianapolis IN
International Classification:
A61K 38/26
C07K 19/00
A61P 3/08
C07K 14/605
US Classification:
514 117, 530308
Abstract:
Modified glucagon peptides are disclosed having improved solubility and stability, wherein the native glucagon peptide has been modified by pegylation, or the addition of a carboxy terminal peptide selected from the group consisting of SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, or both.

Glucagon/Glp-1 Receptor Co-Agonists

US Patent:
2012032, Dec 27, 2012
Filed:
Jun 12, 2012
Appl. No.:
13/494480
Inventors:
Richard D. DiMARCHI - Carmel IN, US
David L. SMILEY - Bloomington IN, US
Bin YANG - Bloomington IN, US
Assignee:
Indiana University Research and Technology Corporation - Indianapolis IN
International Classification:
A61K 38/26
A61P 3/10
A61P 3/04
A61P 3/00
A61P 25/28
C07K 19/00
C07K 17/10
C07K 17/08
C07K 14/605
A61P 1/16
B82Y 5/00
US Classification:
514 53, 530308, 514 72, 514 117, 525 541, 977774, 977915
Abstract:
Provided herein are peptides and variant peptides that exhibit enhanced activity at the GLP-1 receptor, as compared to native glucagon.

Glucagon/Glp-1 Receptor Co-Agonists

US Patent:
2012032, Dec 27, 2012
Filed:
Jun 12, 2012
Appl. No.:
13/494484
Inventors:
Richard D. DiMARCHI - Carmel IN, US
David L. SMILEY - Bloomington IN, US
Assignee:
Indiana University Research and Technology Corporation - Indianapolis IN
International Classification:
A61K 38/26
A61P 3/10
A61P 3/04
A61P 3/00
A61P 25/28
C07K 19/00
C07K 17/10
C07K 17/08
C07K 14/605
A61P 1/16
B82Y 5/00
US Classification:
514 53, 530308, 514 72, 514 117, 525 541, 977774, 977915
Abstract:
Provided herein are peptides and variant peptides that exhibit enhanced activity at the GLP-1 receptor, as compared to native glucagon.

Amazon

David Smiley Photo 62

Albanian Assignment

Author:
David SMILEY
Publisher:
Sphere
Binding:
Paperback
Pages:
192
ISBN #:
0722179332
EAN Code:
9780722179338
David Smiley Photo 63

Apache Solr 4 Enterprise Search Server - Third Edition

Author:
David Smiley, Eric Pugh, Kranti Parisa, Matt Mitchell
Publisher:
Packt Publishing - ebooks Account
Binding:
Paperback
Pages:
479
ISBN #:
1782161368
EAN Code:
9781782161363
If you are a developer who wants to learn how to get the most out of Solr in your applications, whether you are new to the field of search or have used Solr but don t know everything or simply want a good reference, this book is ideal for you. It would be helpful to have some familiarity with basic ...
David Smiley Photo 64

Before You Judge Me: The Triumph And Tragedy Of Michael Jackson's Last Days

Author:
Tavis Smiley, David Ritz
Publisher:
Little, Brown and Company
Binding:
Hardcover
Pages:
288
ISBN #:
0316259098
EAN Code:
9780316259095
A powerful chronicle of the sixteen weeks leading up to King of Pop Michael Jackson's deathMichael Jackson's final months were like the rest of his short and legendary life: filled with deep lows and soaring highs, a constant hunt for privacy, and the pressure and fame that made him socially fragile...

Isbn (Books And Publications)

Albanian Assignment

Author:
David Smiley
ISBN #:
0701128690

Arabian Assignment

Author:
David Smiley
ISBN #:
0850521815

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.